Dry Powder Inhaler Market Size & Share Analysis 2034: Key Trends According to a newly published market research report by 24LifeSciences, global dry powder inhaler device market was valued at USD 756 million in 2024 and is projected to reach USD 1,077 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025-2031. Dry powder inhalers (DPIs) are handheld medical devices that deliver medication to the lungs in the form of a dry, micronized powder. These devices are primarily used to manage chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), offering a propellant-free alternative to traditional metered-dose inhalers. Their operation relies entirely on the patient's inhalation effort to aerosolize and deliver the medication, making them particularly valuable for patients who struggle with coordination issues associated with other inhaler types. The precision and portability of DPIs have established them as a cornerstone of modern respiratory care, with their application expanding to include systemic drug delivery for conditions like diabetes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7295/dry-powder-inhaler-device-market